• M R Kapma, B C Vrouenraets, O E Nieweg, A N van Geel, E M Noorda, A M M Eggermont, and B B R Kroon.
• Department of Surgery, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
• Eur J Surg Oncol. 2005 Feb 1; 31 (1): 95-9.

AimThe aim of this study was to analyse indications and results of amputation for intractable extremity melanoma after failure of isolated limb perfusion (ILP).MethodsBetween 1978 and 2001, 451 patients with loco-regional advanced extremity melanoma underwent 505 ILPs. Amputation of the affected extremity had to be carried out for intractable recurrent disease in 11 of these patients.ResultsThe indications for amputation were uncontrollable pain (n=2), extensive loco-regional tumour progression (n=4), loss of ankle function due to local tumour growth (n=1), and ulcerating and fungating lesions, not responding to other treatments (n=4). Four patients developed stump recurrence after amputation. Ten patients died of melanoma metastases after a median of 11 months (range 2-110 months). Two patients survived more than 5 years after amputation.ConclusionsMajor amputation is rarely indicated for intractable extremity melanoma but long-term survival can be achieved in selected patients.

25 keywords...

hide…